165 related articles for article (PubMed ID: 27110040)
41. Effect of low-level short-term o-xylene inhalation of benzo[a]pyrene (BaP) metabolism and BaP-DNA adduct formation in rat liver and lung microsomes.
Park SH; Schatz RA
J Toxicol Environ Health A; 1999 Nov; 58(5):299-312. PubMed ID: 10598955
[TBL] [Abstract][Full Text] [Related]
42. The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide.
Stiborová M; Sejbal J; Borek-Dohalská L; Aimová D; Poljaková J; Forsterová K; Rupertová M; Wiesner J; Hudecek J; Wiessler M; Frei E
Cancer Res; 2004 Nov; 64(22):8374-80. PubMed ID: 15548707
[TBL] [Abstract][Full Text] [Related]
43. Cytochrome b5 increases cytochrome P450 3A4-mediated activation of anticancer drug ellipticine to 13-hydroxyellipticine whose covalent binding to DNA is elevated by sulfotransferases and N,O-acetyltransferases.
Stiborová M; Indra R; Moserová M; Cerná V; Rupertová M; Martínek V; Eckschlager T; Kizek R; Frei E
Chem Res Toxicol; 2012 May; 25(5):1075-85. PubMed ID: 22390216
[TBL] [Abstract][Full Text] [Related]
44. Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy.
Kotrbová V; Mrázová B; Moserová M; Martínek V; Hodek P; Hudeček J; Frei E; Stiborová M
Biochem Pharmacol; 2011 Sep; 82(6):669-80. PubMed ID: 21683692
[TBL] [Abstract][Full Text] [Related]
45. The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice.
Krais AM; Speksnijder EN; Melis JP; Indra R; Moserova M; Godschalk RW; van Schooten FJ; Seidel A; Kopka K; Schmeiser HH; Stiborova M; Phillips DH; Luijten M; Arlt VM
Arch Toxicol; 2016 Apr; 90(4):839-51. PubMed ID: 25995008
[TBL] [Abstract][Full Text] [Related]
46. In vitro mechanistic differences in benzo[a]pyrene-DNA adduct formation using fish liver and mussel digestive gland microsomal activating systems.
Peters LD; Telli-Karakoç F; Hewer A; Phillips DH
Mar Environ Res; 2002; 54(3-5):499-503. PubMed ID: 12408608
[TBL] [Abstract][Full Text] [Related]
47. DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling.
Stiborová M; Breuer A; Aimová D; Stiborová-Rupertová M; Wiessler M; Frei E
Int J Cancer; 2003 Dec; 107(6):885-90. PubMed ID: 14601046
[TBL] [Abstract][Full Text] [Related]
48. Induction of hepatic cytochrome P450 isozymes, benzo(a)pyrene metabolism and DNA binding following exposure to polycyclic aromatic hydrocarbon residues generated during repeated fish fried oil in rats.
Pandey MK; Yadav S; Parmar D; Das M
Toxicol Appl Pharmacol; 2006 Jun; 213(2):126-34. PubMed ID: 16263147
[TBL] [Abstract][Full Text] [Related]
49. Involvement of cytochrome b5 in the hepatic microsomal metabolism of benzo(a)pyrene.
DeMarco GJ; McCoy GD
Biochem Biophys Res Commun; 1985 Apr; 128(2):621-7. PubMed ID: 4039566
[TBL] [Abstract][Full Text] [Related]
50. Pulmonary microsomal metabolism of benzo[a]pyrene following exposure of rats to silica.
Miles PR; Ma JY; Bowman L; Miller MR
J Toxicol Environ Health; 1996 Aug; 48(5):501-14. PubMed ID: 8751837
[TBL] [Abstract][Full Text] [Related]
51. A monoclonal antibody to rat liver cytochrome P450 IIC11 strongly and regiospecifically inhibits constitutive benzo[a]pyrene metabolism and DNA binding.
Todorovic R; Devanesan PD; Cavalieri EL; Rogan EG; Park SS; Gelboin HV
Mol Carcinog; 1991; 4(4):308-14. PubMed ID: 1872951
[TBL] [Abstract][Full Text] [Related]
52. Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.
Shiizaki K; Kawanishi M; Yagi T
Mutat Res; 2013 Jan; 750(1-2):77-85. PubMed ID: 23036853
[TBL] [Abstract][Full Text] [Related]
53. Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.
Stiborová M; Borek-Dohalská L; Aimová D; Kotrbová V; Kukacková K; Janouchová K; Rupertová M; Ryslavá H; Hudecek J; Frei E
Gen Physiol Biophys; 2006 Sep; 25(3):245-61. PubMed ID: 17197724
[TBL] [Abstract][Full Text] [Related]
54. Effectiveness of human cytochrome P450 3A4 present in liposomal and microsomal nanoparticles in formation of covalent DNA adducts by ellipticine.
Sulc M; Mrizova I; Cerna T; Frei E; Eckschlager T; Adam V; Kopeckova K; Stiborova M
Neuro Endocrinol Lett; 2016 Dec; 37(Suppl1):95-102. PubMed ID: 28263536
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of Catalase Enhances Benzo(a)pyrene Detoxification in Endothelial Microsomes.
Yang F; Yang H; Ramesh A; Goodwin JS; Okoro EU; Guo Z
PLoS One; 2016; 11(9):e0162561. PubMed ID: 27607467
[TBL] [Abstract][Full Text] [Related]
56. Influence of iron (56Fe2O3 or 54Fe2O3) in the upregulation of cytochrome P4501A1 by benzo[a]pyrene in the respiratory tract of Sprague-Dawley rats.
Garçon G; Gosset P; Maunit B; Zerimech F; Creusy C; Muller JF; Shirali P
J Appl Toxicol; 2004; 24(3):249-56. PubMed ID: 15211619
[TBL] [Abstract][Full Text] [Related]
57. Atypical cytochrome P450 induction profiles in glomerular mesangial cells at the mRNA and enzyme level. Evidence for CYP1A1 and CYP1B1 expression and their involvement in benzo[a]pyrene metabolism.
Bowes RC; Parrish AR; Steinberg MA; Willett KL; Zhao W; Savas U; Jefcoate CR; Safe SH; Ramos KS
Biochem Pharmacol; 1996 Aug; 52(4):587-95. PubMed ID: 8759031
[TBL] [Abstract][Full Text] [Related]
58. Cytochrome P450 IIIA1 (P450p) requires cytochrome b5 and phospholipid with unsaturated fatty acids.
Eberhart DC; Parkinson A
Arch Biochem Biophys; 1991 Dec; 291(2):231-40. PubMed ID: 1659320
[TBL] [Abstract][Full Text] [Related]
59. The time-dependent increase in the binding of benzo[a]pyrene to DNA through (+)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide in primary rat hepatocyte cultures results from induction of cytochrome P450IA1 by benzo[a]pyrene treatment.
Eberhart J; Coffing SL; Anderson JN; Marcus C; Kalogeris TJ; Baird WM; Park SS; Gelboin HV
Carcinogenesis; 1992 Feb; 13(2):297-301. PubMed ID: 1740021
[TBL] [Abstract][Full Text] [Related]
60. Suppressive effect of 1-nitropyrene on benzo[a]pyrene-induced CYP1A1 protein expression in HepG2 cells.
Cherng SH; Hsu SL; Yang JL; Yu CT; Lee H
Toxicol Lett; 2006 Mar; 161(3):236-43. PubMed ID: 16280210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
